Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.
about
Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active componentsEpigenetic assays for chemical biology and drug discovery.Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation.Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisSalvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.CD36 as a therapeutic target for endothelial dysfunction in stroke.Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.How can high-throughput screening deliver drugs to treat atherosclerosis?Inhibition of oxidative stress and lipid peroxidation by anthocyanins from defatted Canarium odontophyllum pericarp and peel using in vitro bioassaysCD36 in chronic kidney disease: novel insights and therapeutic opportunities.Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics.Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors.
P2860
Q26825621-E0D222B2-41F7-484F-9E10-CAA2DE8A4882Q30358152-37A6196F-AA21-4D2F-9494-76E7CDE98243Q34089117-B350F5ED-BB70-4851-9ACE-0194A3085C95Q35041476-6BA9D655-99CD-4556-8CF0-E786DE63D740Q35710262-AB488073-8604-4ADA-9B4A-0AF61003F8AEQ36074293-A72AA8CD-5A98-49C3-89C9-074E0595C3AFQ36139754-87F50E1F-1350-4E44-8BE0-616FB4363883Q36317323-23C631C7-51B6-4509-A952-57DF91BF9D9BQ38028514-7BC006E1-5767-4B14-8C44-B984478D5D60Q39035130-EBF1EE97-51B1-4DD2-9C50-43BD29F4F0D4Q41935783-785E7998-2151-44F7-A9CE-5852D1D98B6AQ48048351-B1D48F10-FDE4-4A55-A581-C51B4AEBFCCFQ52561276-E54796F3-BCD2-444C-9CCB-3B356061C5F2Q55325728-4AC3A273-7CBB-4E2C-9767-1914DB1F9BA2
P2860
Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery of antagonists for h ...... gh-throughput screening assay.
@ast
Discovery of antagonists for h ...... gh-throughput screening assay.
@en
Discovery of antagonists for h ...... gh-throughput screening assay.
@nl
type
label
Discovery of antagonists for h ...... gh-throughput screening assay.
@ast
Discovery of antagonists for h ...... gh-throughput screening assay.
@en
Discovery of antagonists for h ...... gh-throughput screening assay.
@nl
prefLabel
Discovery of antagonists for h ...... gh-throughput screening assay.
@ast
Discovery of antagonists for h ...... gh-throughput screening assay.
@en
Discovery of antagonists for h ...... gh-throughput screening assay.
@nl
P2093
P356
P1476
Discovery of antagonists for h ...... gh-throughput screening assay.
@en
P2093
Xiaofang Chen
Yexiang Wu
P304
P356
10.1177/1087057109359686
P577
2010-02-11T00:00:00Z